SCHEMBL345116

SCHEMBL345116

FC(F)(F)c1ccc(CCl)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.52
DAO P14920 3/20 0.45
KDM1A O60341 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
TKT P29401 1/20 0.40
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
KCNH2 Q12809 2/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
KCNQ3 O43525 1/20 0.37
KCNQ2 O43526 1/20 0.37
KCNQ4 P56696 1/20 0.37
KCNQ5 Q9NR82 1/20 0.37
LCK P06239 1/20 0.37
PGR P06401 1/20 0.37
CSF1R P07333 1/20 0.37
CHRM2 P08172 1/20 0.37
HTR1A P08908 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29995657 1.00 TRPV4 (0.52) TRPV4DAOKDM1AMAOAMAOB
Hydrochloric Acid SCHEMBL22400793 0.98 TRPV4 (0.50) TRPV4DAOKDM1AMAOAMAOB
SCHEMBL7996113 0.86 TRPV4 (0.36) TRPV4DAOKDM1AMAOAMAOB
SCHEMBL7995933 0.86 TRPV4 (0.36) TRPV4DAOKDM1AMAOAMAOB
SCHEMBL9840264 0.84 TRPV4 (0.35) TRPV4DAOKDM1AMAOAMAOB
SCHEMBL7999416 0.81 CA1 (0.38) TRPV4DAOKCNH2
SCHEMBL317731 0.79 TRPV4 (0.52) TRPV4DAOKDM1AMAOAMAOB
SCHEMBL129948 0.79 TRPV4 (0.52) TRPV4DAOKDM1AMAOAMAOB
SCHEMBL456311 0.79 TRPV4 (0.57) TRPV4DAOKDM1AMAOAMAOB
SCHEMBL452178 0.79 TRPV4 (0.52) TRPV4DAOKDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 718 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3704094-B1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2026-03-11 EP disclosed
US-20250333411-A1 COMPOUNDS AND METHODS FOR INHIBITING FASCIN CORNELL UNIVERSITY (US) 2025-10-30 US disclosed
US-20250288595-A1 TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS GENZYME CORP (US) 2025-09-18 US disclosed
US-12384790-B2 Pteridinone compounds and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2025-08-12 US disclosed
US-12318392-B2 Tropomyosin-related kinase (trk) inhibitors GENZYME CORPORATION (US) 2025-06-03 US disclosed
US-20250122188-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY CALICO LIFE SCIENCES LLC (US) 2025-04-17 US disclosed
CN-119613392-A Beta amyloid protein probe and preparation method and application thereof 四川大学华西医院 2025-03-14 CN disclosed
WO-2025054431-A1 BENZO-FUSED HETEROCYCLIC COMPOUNDS AND USES THEREOF XENON PHARMACEUTICALS INC. (CA) 2025-03-13 WO disclosed
US-20250059165-A1 PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-02-20 US disclosed
WO-2025031918-A1 PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-02-13 WO disclosed
EP-1466902-A1 ANDROGEN RECEPTOR ANTAGONISTS Takeda Chemical Industries, Ltd. (JP) 2004-10-13 EP disclosed
WO-2004082616-A2 TETRAHYDROPYRANYL CYCLOPENTYL HETEROCYLIC AMIDE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO. INC. (US) 2004-09-30 WO disclosed
EP-1391450-A1 N-(HETEROCYCLE-METHYL)ALKYLAMINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND BACTERICIDE Kureha Chemical Industry Co., Ltd. (JP) 2004-02-25 EP disclosed
US-20040023958-A1 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same AGOURON PHARMACEUTICALS, INC. 2004-02-05 US disclosed
WO-2004006677-A1 MALONONITRILE COMPOUNDS AND THEIR USE AS PESTICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-01-22 WO disclosed
WO-2003095441-A1 INHIBITORS OF HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE, AND COMPOSITIONS AND TREATMENTS USING THE SAME PFIZER INC. (US) 2003-11-20 WO disclosed
EP-0383091-B1 Insecticidally active nitro compounds BAYER AGROCHEM KK (JP) 1993-11-10 EP disclosed
US-5204359-A Insecticidally active nitro compounds NIHON BAYER AGROCHEM K.K. (JP) 1993-04-20 US disclosed
US-5084467-A INSECTICIDALLY ACTIVE NITRO GUANIDINE COMPOUNDS NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1992-01-28 US disclosed
EP-0383091-A1 Insecticidally active nitro compounds NIHON BAYER AGROCHEM K.K. (JP) 1990-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122188-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 TRPV4 3645/4885DAO 4301/4885KDM1A 4651/4885
US-12318392-B2 Tropomyosin-related kinase (trk) inhibitors NTRK1, NGF, NTRK2 TRPV4 1778/4885DAO 3493/4885KDM1A 2889/4885
US-20250333411-A1 COMPOUNDS AND METHODS FOR INHIBITING FASCIN FSCN1, MTPN, MYOF TRPV4 3463/4885DAO 1966/4885KDM1A 4649/4885
US-20040023958-A1 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same POLRMT, RNGTT, RNASE1 TRPV4 4854/4885DAO 984/4885KDM1A 1431/4885
US-20250059165-A1 PIPERIDINYLPYRIDINYLCARBONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN QPCT, QPCTL, GLUL TRPV4 4677/4885DAO 1247/4885KDM1A 3463/4885
US-20250288595-A1 TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS NTRK1, NGF, NTRK2 TRPV4 1778/4885DAO 3493/4885KDM1A 2889/4885
US-12384790-B2 Pteridinone compounds and uses thereof DPYD, PKD1, TYMP TRPV4 4185/4885DAO 1329/4885KDM1A 691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.